A Phase II, Open-label, Multicentre, Pharmacokinetic, Pharmacodynamics and Safety Study of a New Paediatric Eurartesim Dispersible Formulation and Crushed Film Coated Eurartesim Tablet, in Infant Patients With P. Falciparum Malaria
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Pharmacokinetics
- Sponsors sigma-tau SpA
- 08 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2014 Planned End Date changed from 1 Feb 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
- 09 Apr 2014 Planned End Date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.